Socioeconomic determinants of prescribed and non-prescribed medicine consumption in Austria

European Journal of Public Health

Volumn 25, Issue 4, 2015, Pages 597-603

  Mayer, Susanne ^a,b   Österle, August ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b VIENNA UNIVERSITY OF ECONOMICS AND BUSINESS   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ADULT; AGE DISTRIBUTION; AGED; AUSTRIA; DRUG UTILIZATION; FEMALE; HEALTH CARE DELIVERY; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; SEX RATIO; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

ADULT; AGE DISTRIBUTION; AGED; AUSTRIA; DRUG UTILIZATION; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; NONPRESCRIPTION DRUGS; PRESCRIPTION DRUGS; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS;

EID: 84939619154     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/cku179     Document Type: Article

References (38)

1. Van Doorslaer E, Masseria C. Income-Related Inequality in the Use of Medical Care in 21 OECD Countries. OECD Health Working Paper No. 14. Paris: OECD Publishing, 2004
2. Van Doorslaer E, Jones A. Income-related inequality in health, and health care in the European Union. Health Econ 2004; 13: 605-8
3. Bago d'Uva T, Jones A, Van Doorslaer E. Measurement of horizontal in equity in health care utilisation using European panel data. J Health Econ 2009; 28: 280-9
4. Devaux M, De Looper M. Income-Related Inequalities in Health Service Utilisation in 19 OECD Countries, 2008-2009. OECD Health Working Paper No. 58. Paris: OECD Publishing, 2012
5. Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc 2011; 86: 304-14
6. Nielsen M, Hansen E, Rasmussen N. Patterns of psychotropic medicine use, and related diseases across educational groups: national cross-sectional survey. Eur J Clin Pharmacol 2004; 60: 199-204
7. Manderbacka K, Keskimäki I, Reunanen A, Klaukka T. Equity in the use of antithrombotic drugs, beta-blockers, and statins among Finnish coronary patients. Int J Equity Health 2008; 7: 16
8. Butterworth P, Olesen S, Leach LS. Socioeconomic differences in antidepressant use in the PATH Through Life Study: evidence of health inequalities, prescribing bias, or an effective social safety net? J Affect Disord 2013; 149: 75-83
9. Hjern A, Haglund B, Rosen M. Socioeconomic differences in use of medical care, and antibiotics among schoolchildren in Sweden. Eur J Public Health 2011; 11: 280-3
10. Holstein BE, Hansen EH, Pernille D. Social class variation in medicine use among adolescents. Eur J Public Health 2004; 14: 49-52
11. Haider S, Johnell K, Thorslund M, Fastbom J. Analysis of the association between polypharmacy, and socioeconomic position among elderly aged or =77 years in Sweden. Clin Ther 2008; 30: 62-9
12. Pappa E, Kontodimopoulos N, Papadopoulos AA, et al. Prescribed drug utilization, and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health services utilization, and lifestyle factors. Eur J Clin Pharmacol 2010; 67: 185-92
13. Thorell K, Skoog J, Zielinski A, et al. Licit prescription drug use in a Swedish population according to age, gender, and socioeconomic status after adjusting for level of multi-morbidity. BMC Public Health 2012; 12: 575
14. Nordin M, Dackehag M, Gerdtham U. Socioeconomic inequalities in drug utilization for Sweden: evidence from linked survey, and register data. Soc Sci Med 2013; 77: 106-17
15. Du Y, Knopf H. Self-medication among children, and adolescents in Germany: results of the National Health Survey for Children, and Adolescents (KiGGS). Br J Clin Pharmacol 2009; 68: 599-608
16. Nielsen M, Hansen E, Rasmussen N. Prescription, and non-prescription medicine use in Denmark: association with socio-economic position. Br J Clin Pharmacol 2003; 59: 677-84
17. Daban F, Pasarin M, Rodriguez-Sanz M, et al. Social determinants of prescribed, and non-prescribed medicine use. Int J Equity Health 2010; 9: 12
18. Österle A. Austria: a health care system between continuity, and gradual changes. In: Pavolini E, Guillén AM, editors. Health Care Systems in Europe under Austerity: Institutional Reforms, and Performance. Basingstoke: Palgrave Macmillan, 2013: 147-68
19. Vogler S, Leopold C. WHO Pharmaceutical Country Profile-Austria. Vienna: Gesundheit Österreich GmbH, 2010
20. Zimmermann N, Vogler S. PPRI/PHIS Pharma Profile AUSTRIA. Vienna: PPRI/PHIS, 2012
21. Hofmarcher M, Quentin W. Austria: health system review. Health Syst Transit 2013; 15: 1-291
22. Klimont J, Kytir J, Leitner B. Österreichische Gesundheitsbefragung 2006/2007: Hauptergebnisse und Methodische Dokumentation [Austrian Health Interview Survey 2006/2007: Main Results, and Methodological Documentation]. Vienna: Statistik Austria, 2007. 23 Statistik Austria. Standard-Dokumentation Metainformationen (Definitionen, Erläuterungen, Methoden, Qualität) zu Österreichische Gesundheitsbefragung 2006/2007 [Standard Documentation Metainformation (Definitions, Explanations, Methods, Quality) for Austrian Health Interview Survey 2006/07]. Vienna: Statistik Austria, 2009
23. Böheim M, Pichler E. Der österreichische Selbstmedikationsmarkt [The market for self-medication in Austria]. Wirtschaftspolitische Blätter 2011; 2: 347-68
24. De Looper M, Lafortune G. Measuring Disparities in Health Status, and in Access, and Use of Health Care in OECD Countries. OECD Health Working Paper No. 43. Paris: OECD Publishing, 2009
25. HLS-EU CONSORTIUM. Comparative Report of Health Literacy in Eight EU Member States. The European Health Literacy Survey HLS-EU, 2012
26. OECD. What Are Equivalence Scales? OECD Project on Income Distribution, and Poverty, 2009. Available at: http://www.oecd.org/social/family/35411111.pdf (9 May 2013, date last accessed
27. Hoffmann K, Stein VK, Maier M, et al. Access points to the different levels of health care, and demographic predictors in a country without a gatekeeping system. Results of a cross-sectional study from Austria. Eur J Public Health 2013; 23: 933-9
28. Mackenbach JP, Stirbu I, Roskam AJ, et al. Socioeconomic inequalities in health in 22 European countries. N Engl J Med 2008; 358: 2468-81
29. Burkert N, Rasky E, Freidl W. Social inequalities regarding health, and health behaviour in Austrian adults. Wien Klin Wochenschr 2012; 124: 256-61
30. Eggen A. Patterns of medicine use in a general population (0-80 years): the influence of age, gender, diseases, and place of residence on drug use in Norway. Pharmacoepidemiol Drug Saf 1997; 6: 179-87
31. Metge C, Black C, Peterso S, Kozyrskyj A. The population's use of pharmaceuticals. Med Care 1999; 37: JS42-59
32. Fernandez-Liz E, Modamio P, Catalan A, et al. Identifying how age, and gender influence prescription drug use in primary health care environment in Catalonia, Spain. Br J Clin Pharmacol 2008; 65: 407-17
33. Thomas H, Sweetnam P, Janchawee B, Luscombe D. Polypharmacy among South Wales. Eur J Clin Pharmacol 1999; 55: 411-5
34. WHO. Manual for the Household Survey to Measure Access, and Use of Medicines. Available at: http://www.who.int/medicines/areas/coordination/household-manual-february-2008.pdf (26 May 2014, date last accessed
35. Larsen J, Stovring H, Kargstrup J, Hansen DG. Can differences in medical drug compliance between European countries be explained by social factors: analyses based on data from the European Social Survey, round 2. BMC Public Health 2009; 9: 145
36. Gemmill M, Thomson S, Mossialos E. What impact do prescription drug charges have on efficiency, and equity? Evidence from high-income countries. Int J Equity Health 2008; 7: 12
37. Habl C, Bachner F, Klinser D, Ladurner J. The Austrian Health Care System: Key Facts. Vienna: Austrian Federal Ministry of Health, 2010
38. Czypionka T, Riedel M, Röhrling G, et al. Mengenkontrolle im Arzneimittelbereich: internationale Evidenz für Österreich [Controlling the quantity in pharmaceutical use: international evidence for Austria]. Health Syst Watch 2010; 3: 1-16